PT  - JOURNAL ARTICLE
AU  - García-Iglesias, Daniel
AU  - de Cos Juez, Francisco Javier
TI  - Early behavior of Madrid Covid-19 disease outbreak: A mathematical model
AID  - 10.1101/2020.03.30.20047019
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.30.20047019
4099  - http://medrxiv.org/content/early/2020/04/01/2020.03.30.20047019.short
4100  - http://medrxiv.org/content/early/2020/04/01/2020.03.30.20047019.full
AB  - Introduction Madrid Covid-19 disease outbreak started on 28 February 2020 and since then it became the main Covid-19 disease cluster in Spain. On 26 March 2020, a total of 17166 cases were already reported, with 2090 deaths. Globally a R0 index of 2-3 has been reported. We aimed to build an experimental mathematical model that help to analyze the early characteristics of Madrid Covid-19 disese outbreak and to explore the actual R0 index on Madrid Covid-19 outbreak.Material and Methods A simulated mathematical model was built, based on a SIR epidemiological model and the reported characteristics of Wuhan Covid-19 disease outbreak. Monte Carlo simulations were further done to estimate the R0 value over time in the Madrid Covid-19 disease outbreak.Results Mean estimated R0 value along the early period is of 2.22 (+/-1.21 SD). A significant increase of 0.093 (+/-0.037, p=0.025) in R0 value each day of outbreak is found.Conclussions Our proposed Mathematical Simulation model may be useful to evaluate early characteristics of this outbreak. The present work is the first reported estimation of R0 value in the Spanish Madrid Covid-19 outbreak, with similar results to the previous reported in the Wuhan outbreak, although it may suggest a slightly increase on R0 along time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the Spanish Health minister webpage. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/situacionActual.htm